Il trattamento dello pseudomixoma peritonei (PMP) mediante citoriduzione e chemioipertermia intraperitoneale (CIIP).

Translated title of the contribution: Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy

S. Scuderi, D. Costamagna, M. Vaira, R. Barone, M. De Simone

Research output: Contribution to journalArticlepeer-review

Abstract

Pseudomixoma peritonei (PMP) is a rare neoplasia with a low grade of clinical malignity. Generally, the main treatment of this tumor is the surgical debulking. Best results are obtained combining surgery and hyperthermic antiblastic peritoneal perfusion (HAPP) with CDDP and MMC. From April '97 to March 2003, we operated on 132 patients, 8 times with a palliative intent. In 27 times we achieved a complete cytoreduction (17 CC0 and 10 CC1) followed by HAPP. As regards results, no post-operative mortality was reported and 19% of major morbidity was observed. 26 patients are NED at maximum follow-up of 6 years and 1 patient had recurrence 6 months after primary resection. We believe that cytoreduction and HAPP is the golden standard of PMP therapy when it is possible to achieve a complete cytoreduction. Most of the times, the disease is not radically treated and therefore, after diagnosis, patients should be only referred to specialized centers.

Translated title of the contributionTreatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy
Original languageItalian
Pages (from-to)43-45
Number of pages3
JournalTumori
Volume89
Issue number4 Suppl
Publication statusPublished - Jul 2003

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy'. Together they form a unique fingerprint.

Cite this